Volume | 459,163 |
|
|||||
News | - | ||||||
Day High | 121.45 | Low High |
|||||
Day Low | 119.735 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Zimmer Biomet Holdings Inc | ZBH | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
121.45 | 119.735 | 121.45 | 121.30 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
11,857 | 459,163 | $ 120.29 | $ 55,234,669 | - | 102.00 - 149.25 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:32:05 | 100 | $ 119.90 | USD |
Zimmer Biomet (ZBH) Options Flow Summary
Zimmer Biomet Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
24.63B | 205.08M | - | 7.39B | 1.02B | 4.99 | 24.06 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Zimmer Biomet News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZBH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 128.55 | 128.55 | 119.57 | 123.56 | 1,253,571 | -8.65 | -6.73% |
1 Month | 126.99 | 133.90 | 119.57 | 127.44 | 1,161,379 | -7.09 | -5.58% |
3 Months | 119.98 | 133.90 | 119.13 | 125.87 | 1,407,529 | -0.08 | -0.07% |
6 Months | 106.59 | 133.90 | 102.33 | 119.24 | 1,600,499 | 13.31 | 12.49% |
1 Year | 133.98 | 149.25 | 102.00 | 123.39 | 1,589,222 | -14.08 | -10.51% |
3 Years | 171.92 | 180.36 | 100.39 | 127.47 | 1,462,976 | -52.02 | -30.26% |
5 Years | 119.66 | 180.36 | 74.37 | 129.59 | 1,377,875 | 0.24 | 0.20% |
Zimmer Biomet Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products. |